0000899243-23-010999.txt : 20230410 0000899243-23-010999.hdr.sgml : 20230410 20230410103945 ACCESSION NUMBER: 0000899243-23-010999 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230406 FILED AS OF DATE: 20230410 DATE AS OF CHANGE: 20230410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klencke Barbara CENTRAL INDEX KEY: 0001647647 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 23810043 MAIL ADDRESS: STREET 1: C/O SIERRA ONCOLOGY, INC. STREET 2: 1820 GATEWAY DRIVE, SUITE 110 CITY: SAN MATEO STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-06 0 0001783328 TScan Therapeutics, Inc. TCRX 0001647647 Klencke Barbara C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451 1 0 0 0 0 Stock Option (Right to Buy) 2.20 2023-04-06 4 A 0 9146 0.00 A 2033-04-05 Voting Common Stock 9146 9146 D The shares subject to this option shall vest and become exercisable in thirty-six equal monthly installments following April 6, 2023, subject to the Reporting Person's continued service at such time. /s/ Barbara Klencke 2023-04-10